Follow The Filings

ACA Arcosa

Arcosa earnings company data as of 3:00 PM ET 10/23

Scheduled

1 period, newest first, nothing reported yet. Each row shows EPS above revenue.

Period Date Metric Estimate Actual Result
FY2026 Q3 29 Oct EPS 1.56 — —
Rev — — —

Insider trades

Open-market buys and sales by ACA's executives, directors and 10% owners in the last 12 months, from their Form 4s

All ACA insider trades
  • None no insider bought on the open market
  • None no sales outside a trading plan
  • None no planned (10b5-1) sales

No open-market buys or sales on file.

Also filed in the last 12 months, not counted as buying or selling: 21 stock grants, 12 share withholdings for taxes, 6 gifts, and 1 other transaction.

SEC filings

Recent issuer filings from EDGAR, 17 shown.

Filed Form Detail Links
8-K 1.02,2.01,3.01,3.03,5.01,5.02,5.03,9.01
8-K 5.07
DEFA14A
8-K 2.02,9.01
10-Q
DEFA14A
8-K 1.04
SCHEDULE 13G/A —
8-K 1.01,7.01,9.01
DEFA14A
DEFA14A
DEFA14A
DEFA14A
DEFA14A
8-K 7.01,9.01
8-K 5.07,9.01
10-Q

Estimates are consensus figures; SEC filings remain the official record. Not investment advice.